Therefore, as a first step, we performed in culture BMI-1 inhibition studies, using Unesbulin to assess its effects in culture on the human BMI-1+ NSCLC cell line H1975 (25), which carries T790M/L858R mutations in EGFR (25). The gene discussed is BMI1; the disease is non-small cell lung carcinoma.